Literature DB >> 22134932

Natriuretic peptides as markers of cardiovascular risk: the story continues.

Hector O Ventura, Marc A Silver.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22134932      PMCID： PMC3228612          DOI： 10.4065/mcp.2011.0725

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  20 in total

1.  Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Authors:  Stefan Blankenberg; Matthew J McQueen; Marek Smieja; Janice Pogue; Cynthia Balion; Eva Lonn; Hans J Rupprecht; Christoph Bickel; Laurence Tiret; Francois Cambien; Hertzel Gerstein; Thomas Münzel; Salim Yusuf
Journal:  Circulation       Date:  2006-07-10       Impact factor: 29.690

2.  Use of biomarkers to "guide" care in chronic heart failure: what have we learned (so far)?

Authors:  James L Januzzi
Journal:  J Card Fail       Date:  2011-08       Impact factor: 5.712

3.  The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

Authors:  Paul M McKie; Alessandro Cataliotti; Brian D Lahr; Fernando L Martin; Margaret M Redfield; Kent R Bailey; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

4.  N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Reena Gupta; Beeya Na; Alan H B Wu; Nelson B Schiller; Mary A Whooley
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

5.  Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.

Authors:  Paul M McKie; Alessandro Cataliotti; S Jeson Sangaralingham; Tomoko Ichiki; Valentina Cannone; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

6.  Can a cardiac peptide predict mortality in human hypertension?

Authors:  Valentina Cannone; Paul M McKie; John C Burnett
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

Review 7.  The endocrine function of the heart.

Authors:  Monica Forero McGrath; Mercedes L Kuroski de Bold; Adolfo J de Bold
Journal:  Trends Endocrinol Metab       Date:  2005-11-02       Impact factor: 12.015

8.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

Authors:  J A de Lemos; D A Morrow; J H Bentley; T Omland; M S Sabatine; C H McCabe; C Hall; C P Cannon; E Braunwald
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

9.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

10.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330
View more
  2 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

2.  N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.

Authors:  Graziella Bruno; Andrea Landi; Federica Barutta; Giuseppe Ghezzo; Claudio Baldin; Laura Spadafora; Andrea Schimmenti; Tania Prinzis; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.